Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Ahmad Moolla


  • Project: Using Multi-Parametric Magnetic Resonance Techniques to determine the severity and response to treatment of liver fibrosis, inflammation, steatosis and iron in patients with type 2 diabetes and non-alcoholic fatty liver disease.

Ahmad was awarded a University of Oxford - Novo Nordisk Clinical Research Fellowship where he worked with Prof Jeremy Tomlinson and Prof Stefan Neubauer at the Oxford Centre for Diabetes, Endocrinology & Metabolism (OCDEM) and the Oxford Centre for Clinical Magnetic Resonance Research (OCMR).

His research fellowship focussed on non-alcoholic (metabolic associated) fatty liver disease (NAFLD / MAFLD) which is the commonest cause of chronic liver disease worldwide and affects up to 70% of patients with type 2 diabetes. He led a number of human studies including a UK MHRA and UK HRA registered clinical trial (CTIMP) investigating the use of GLP-1 agonists to treat NAFLD which delivered significant advances in understanding the mechanisms through which these agents improve NAFLD. His research resulted in the award of a number of prizes including the prestigious UK Society for Endocrinology 2017 Early Career Prize for his work on developing novel non-invasive steroid biomarker tools coupled with machine learning techniques to screen for NAFLD and to stage liver fibrosis.

Ahmad was awarded his DPhil (PhD) based on this programme of research. His research has been presented nationally and internationally in the USA, Asia and across Europe, and has been published in high impact scientific journals. Furthermore, Ahmad has been invited to lecture internationally on the topics of diabetes, obesity and NAFLD as well as more generally on medical education and the structure of UK health services.

Ahmad is currently a Consultant Physician at the Royal Free Hospital in London where he specialises and is board certified (UK CCT) in Diabetes, Endocrinology and General Internal Medicine (GIM). He continues to pursue clinical research interests in diabetes, obesity and NAFLD. His medical training was undertaken at Imperial College London where he also held UK National Institute for Health Research (NIHR) Academic Clinical Fellowships. His clinical practice is complemented by interests in undergraduate and postgraduate medical education, clinical leadership and health policy. He holds a Masters in Education and previously worked at the UK Department of Health as a Clinical Advisor to the NHS National Medical Director for England. His work aims to improve the quality of life and outcomes for patients living with diabetes, obesity and cardio-metabolic illnesses. He delivers this through providing high quality, patient-centred and evidenced-based treatments and systems of care.